Thymosin Beta 4

DRUG5 trials

Sponsors

RegeneRx Biopharmaceuticals, Inc., ReGenTree, LLC

Conditions

Dry EyeDry Eye SyndromeEpidermolysis BullosaMyocardial InfarctionMyocardial IschemiaPressure UlcersVenous Stasis Ulcers

Phase 1

A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers

WithdrawnNCT00743769

RegeneRx Biopharmaceuticals, Inc.Myocardial Infarction, Myocardial Ischemia

Start: 2008-04-30End: 2017-01-01Updated: 2017-04-17

Phase 2

A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa

TerminatedNCT00311766

RegeneRx Biopharmaceuticals, Inc.Epidermolysis Bullosa

Start: 2006-02-28End: 2012-11-30Updated: 2014-05-12

Study of Thymosin Beta 4 in Patients With Pressure Ulcers

CompletedNCT00382174

RegeneRx Biopharmaceuticals, Inc.Pressure Ulcers

Start: 2006-05-31End: 2008-12-31Updated: 2010-02-01

Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers

CompletedNCT00832091

RegeneRx Biopharmaceuticals, Inc.Venous Stasis Ulcers

Start: 2006-07-31End: 2009-01-31Updated: 2010-03-30

Safety and Efficacy of Thymosin Beta 4 Ophthalmic Solution in Patients With Dry Eye

CompletedNCT01387347

ReGenTree, LLCDry Eye, Dry Eye Syndrome

Start: 2011-08-31End: 2011-12-31Updated: 2015-07-10